2026 Update on the Management of Diffuse Large B-Cell Lymphoma.
This review outlines the current and emerging management strategies for diffuse large B‑cell lymphoma (DLBCL), emphasi...
Epcoritimab Combo Could Be New Standard for Some FLs.
- Post category:Cancers of the Lymphatic System
- Reading time:1 min read
The report describes results from the pivotal phase III EPCORE LF-1 trial in relapsed/refractory follicular lymphoma, a...
Tisagenlecleucel yields superior patient-reported health-related quality of life compared to autologous stem cell transplantation in patients with relapsed/refractory large B-cell lymphomas.
- Post category:Cancers of the Lymphatic System
- Reading time:2 mins read
This study compared health-related quality of life (HRQoL) in patients with relapsed/refractory large B‑cell lymphoma...
A retrospective study of treatment and outcomes in synchronous systemic and central nervous system large B-cell lymphoma.
- Post category:Cancers of the Lymphatic System
- Reading time:2 mins read
Study type and population - Retrospective cohort from two centers over 21 years - 63 consecutive, previously untreat...
Late failure of aggressive B-cell lymphoma after CAR T-cell therapy: a LYSA study from the DESCAR-T registry.
- Post category:Cancers of the Lymphatic System
- Reading time:2 mins read
This study uses the French DESCAR-T real-world registry to characterize patients with large B‑cell lymphoma (LBCL) who...
Population-wide introduction of dose-adjusted EPOCH-R in high-grade B-cell lymphoma with MYC/BCL2 rearrangements, DLBCL morphology.
- Post category:Cancers of the Lymphatic System
- Reading time:2 mins read
This study evaluated whether implementing a provincial guideline favoring DA‑EPOCH‑R for fit patients (≤75 years)...